Alcohol Abuse Clinical Trials
2 recruiting trials for Alcohol Abuse. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Alcohol Abuse clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of Houston (1), Johns Hopkins Bloomberg School of Public Health (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Mobile Application (behavioral, 1 trial), followed by Bright Horizons, Case Management.
Track Alcohol Abuse trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
A Mobile Intervention for Black Individuals Who Engage in Hazardous Drinking
The purpose of this study is to develop and examine a culturally adapted, mobile health application for the Android and iOS platform. The application uses a personalized feedback...
Adaptation and Evaluation of Bright Horizons
This study will test if a program called 'Bright Horizons' is effective at reducing binge substance use among adolescents. Bright Horizons is a culturally adapted intervention...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Alcohol Abuse, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Alcohol Abuse, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Alcohol Abuse, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.